Conférences - Pharmacologie et développement des médicaments - États-Unis

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.
 
5th Antiviral Drugs Research & Development Conference
ID
792172
Dates
01 jui 2016 - 02 jui 2016
Lieu
San Diego, États-Unis
Résumé
We invite you to attend the 5th Antiviral Drugs Research & Development Conference, which will take place June 1-2, 2016 in San Diego, CA. This conference will bring together an exciting balance of industry and academia, where drug and vaccine designs in HIV, RSV, Hepatitis B/C, Influenza, etc. will be discussed. Top researchers will share their experiences with new inhibitory mechanisms, longer acting drugs, and strategies en route for cures. Delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the research in antiviral drugs.
Contact
Kristen Starkey;     Tél.: [626-256-6405];     Email.: infogtcbio@gtcbio.com
Sujets
HIV, Zika, Antiviral Drugs
2.
 
2nd Bugs & Drugs: Antibacterial Drug Discovery Conference (June 1-2, 2016, San Diego, CA)
ID
793725
Dates
01 jui 2016 - 02 jui 2016
Lieu
San Diego, États-Unis
Résumé
We invite you to attend the 2nd Bugs & Drugs: Antibacterial Drug Discovery Conference, which will take place on June 1-2, 2016 in San Diego, CA.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Bugs, Drugs, Antibacterial, Drug, Discovery
Sujets apparentés
3.
 
Infectious Diseases World Summit
ID
793734
Dates
01 jui 2016 - 03 jui 2016
Lieu
San Diego, États-Unis
Résumé
We invite you to attend the Infectious Diseases World Summit, which will take place on June 1-3, 2016 in San Diego, CA.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Infectious, Diseases
Sujets apparentés
4.
 
14th Vaccines Research & Development Conference
ID
792171
Dates
02 jui 2016 - 03 jui 2016
Lieu
San Diego, États-Unis
Résumé
Newly emerging infections have opened up dialogue about the need for novel treatments and government response to such infections. As we continue to search for solutions, we must review the lessons learned from research and industry response in order to overcome the current challenges. There are a number of exciting new developments including traditional vaccines and application of vaccines to new diseases, such as cancer vaccines. We will also discuss innovative efficacy trials and how to accelerate vaccine development. Join us as colleagues from industry and academia gather to discuss newly licensed vaccines, new vaccine technologies, RNA-based vaccines, and adjuvant discovery.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Vaccine, HIV, Zika
Sujets apparentés
5.
 
13th Anti-Infectives Partnering & Deal-Making Conference (June 2-3, 2016, San Diego, CA)
ID
793768
Dates
02 jui 2016 - 03 jui 2016
Lieu
San Diego, États-Unis
Résumé
GTCbio is proud to present the 13th Anti-Infectives Partnering & Deal-Making Conference, to be held on June 2-3, 2016 in San Diego, CA.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Anti-Infectives, Partnering, Deal-Making
Sujets apparentés
6.
 
2016 Ross Prize in Molecular Medicine: Resolution of Inflammation
ID
797104
Date de début
13 jui 2016
Lieu
New York, États-Unis
Résumé
The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine. The Ross Prize recognizes biomedical scientists whose discoveries have changed the way medicine is practiced. The prize is awarded to midcareer scientists who have made a significant impact in the understanding of human disease pathogenesis and/or treatment and who hold significant promise for making even greater contributions to the general field of molecular medicine.

The 2016 Ross Prize in Molecular Medicine will be awarded to Dr. Charles N. Serhan for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases. With his instrumental finding that inflammation is an active process, Dr. Serhan has undertaken a multidisciplinary systems biology approach to elucidate the underlying molecular mechanisms of various inflammatory pathologies and develop novel compounds for treating these diseases.

Sujets apparentés
7.
 
WPC — 15th Annual World Preclinical Congress
ID
799352
Dates
14 jui 2016 - 17 jui 2016
Lieu
Boston, MA, États-Unis
Résumé
In recent years, the World Preclinical Congress (WPC) has turned into a key networking event for those involved in preclinical research. It features conferences, training seminars and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. WPC attracts a diverse, global audience, which include experts, as well as people who are new and eager to contribute to the field. Having chemists, biologists, pharmacologists, toxicologists, screening and formulation experts in attendance, creates an interesting cross-disciplinary environment for tackling challenges and sharing expertise. Now in its 15th year the event will continue to highlight ways to improve accuracy and efficiency in preclinical research, while bringing together the people and technologies to make it happen. As always, we ask those of you involved in preclinical work to try and help innovate traditional drug discovery by bringing along your ideas, showcasing new technologies, and fostering new collaborations. WPC is indeed the event “Where Preclinical Minds Meet Discovery Technologies” and we hope you can join this dynamic community to help shape the future of preclinical research!
Contact
Tél.: [7819725400];     Email.: chi@healthtech.com
Sujets
oncology, preclinical, toxicity, medical, chemistry, cell technology, drug discovery, drug development
Sujets apparentés
8.
 
ComplianceOnline Pharma Summit 2016 – Risk Control and Compliance
ID
796086
Dates
16 jui 2016 - 17 jui 2016
Lieu
Philadelphia, États-Unis
Résumé
Pharmaceutical and biotechnology companies across the globe face unprecedented challenges in the dynamically changing clinical, regulatory and business landscape. Aging populations, chronic diseases, technology and treatment advances are expected to spur health sector growth in 2016. As we approach 2016, it is imperative that leaders in the pharma space understand the trends and shifts happening around them.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Pharma Summit 2016 - Risk control & Compliance, Biopharma summit 2016, Pharma Conferences, Pharma Events, Biotech Pharma Conclave
9.
 
The A to Z's of Microbial Control, Monitoring and Validation of Water Systems for Pharmaceuticals, Biologics, Medical Devices, Cosmetics, and Personal Care Products
ID
810943
Dates
16 jui 2016 - 17 jui 2016
Lieu
Newark, États-Unis
Résumé
All facilities manufacturing pharmaceuticals, biologics, medical devices, cosmetics, and personal care products are likely to have high purity water systems. In spite of this purity, microorganisms can flourish within these systems and lead to undesirable contamination of facility processes and their products. Of all the individuals at the facility, it is site’s microbiologists who should understand the microorganisms in water systems and how best to monitor and control them. Sadly, this is often not the case due to the lack of familiarity with biofilm and its impact on water system sampling, testing, sanitization, and routine maintenance. This lack of understanding of microbial control often leads to poor system designs, poor system sampling, poor system maintenance and poor sanitization practices, and as a result, ongoing microbial problems with the water.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Pharmaceutical water systems seminar, water system compliance seminar, water system microbial control, water system microbial monitoring
10.
 
Design of Experiments (DOE) for Process and Product Optimization
ID
810942
Dates
16 jui 2016 - 17 jui 2016
Lieu
Philadelphia, États-Unis
Résumé
This course is designed to help scientists and engineers plan and conduct experiments and analyze the data to develop predictive models used to optimize processes and products and solve complex problems. DOE is an extremely efficient method to understand which variables (and interactions) affect key outcomes and allows the development of mathematical models used to optimize process and product performance. The models also provide an understanding of the impact of variability in controllable and uncontrollable factors on important responses. The concepts behind DOE are covered along with some effective types of screening experiments. Case studies will also be presented to illustrate the use of the methods.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
DOE, design of experiments, DOE techniques, data sets, key tools, good experimental practices, Experimental Design, Mathematical Models
11.
 
Minnesota NMR Center 4th Annual Advanced Protein Workshop
ID
810546
Dates
20 jui 2016 - 24 jui 2016
Lieu
Minneapolis, MN, États-Unis
Résumé
This summer, the Minnesota NMR Center will offer once again, the annual "hands on" advanced NMR workshop, in which attendees will have the opportunity to learn methods applicable to both soluble and membrane-bound proteins. Not only will graduate students and postdoctoral associates familiarize themselves with state-of-the-art multidimensional techniques in solution NMR spectroscopy, but they will also be given an introduction to solid-state NMR methods and an opportunity to apply them to membrane-bound proteins.
Sujets
NMR, NMR Spectroscopy, Workshop, Conference, solid-state, solution, membrane, protein, spectra, structure, biology, chemistry, physical, Minnesota, TopSpin, VNMRJ, nmrPipe, Sparky, Rosetta, sequential assignments, structure analysis, protein dynamics.
12.
 
5th Annual Drug Repositioning, Repurposing and Rescue Conference
ID
759860
Dates
21 jui 2016 - 22 jui 2016
Lieu
Chicago, États-Unis
13.
 
2016 Canadian Pharma Market Research Conference
ID
807136
Dates
22 jui 2016 - 23 jui 2016
Lieu
Toronto, États-Unis
Résumé
The Canadian Pharma Market Research Conference (June 22-23, 2016, Toronto) is the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. The Canadian Pharma Market Research Conference provides a focus on Canada, yet also frames the dialogue within the context of the global pharma industry. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities.
Contact
Ross Frasier;     Email.: ross@pharmaciconference.com
14.
 
FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials
ID
806296
Dates
23 jui 2016 - 24 jui 2016
Lieu
Boston, États-Unis
Résumé
Manufacturing an investigational product for the initial pilot clinical trials could pose a considerable logistical and financial challenge to developers. The first-in-man and pilot clinical trials are usually conducted in very small number of healthy participants with lower doses primarily to establish safety and hence do not need a significant amount of investigational material. The US FDA allows developers to test early stage investigational products under relaxed GMP requirements. The manufacturing requirements for early stage clinical trials are designed to assure adequate quality of the investigational product being tested without the excessive regulatory burden of full-scale GMP manufacturing. This workshop will present the current regulations, guidance documents and regulatory strategies available for manufacturing an early development stage product for Phase I and first-in-man clinical trials. Also discussed will be logistical issues with managing the supply of an early stage investigational product, and requirements for stability testing, storage and shipping, labeling, and documentations. Perspectives for different classes of products will be presented using case studies.
Contact
Peter Brown;     Tél.: [+1 410-501-5777];     Email.: pbrown@fdamap.com
Sujets
FDA GMP Regulations, FDA GMP Guidance, GMP for Phase 1, Good Manufacturing Practices, Phase 1 in Clinical Trials, Clinical Trials Regulations, Raw Materials Management
15.
 
Understanding the Statistical Considerations for Quantitative ICH Guidelines
ID
810951
Dates
23 jui 2016 - 24 jui 2016
Lieu
San Francisco, États-Unis
Résumé
This course is designed to introduce to individuals the understanding and interpretation of the statistical concepts with reference to certain quantitative ICH Guidelines that apply across laboratory (drug development) and clinical development (drug/device) procedures such as analytical methods in validation and acceptance criteria in calibration procedures, risk management and process monitoring as well as dealing with uncertainties and other relevant issues. It is not a course in statistics but introduces the participant to a hands on approach to the statistical techniques one uses, how they are applied and reasonably interpreted and understood. One will address the various challenges facing pharmaceutical and biotechnology companies when it comes to quantifying results in a meaningful interpretable manner through tabulations and graphical presentations.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Statistical considerations for quantitative ich guidelines training, quantitative measurement procedures, sensitivity of the sample size
16.
 
Designing and Sustaining New and Existing Product Stability Testing Program
ID
810994
Dates
23 jui 2016 - 24 jui 2016
Lieu
San Francisco, États-Unis
Résumé
New or existing modified drug Stability Testing Program's regulations/requirements stipulated by the FDA, 21 CFR or other regulations may sometimes creating an overwhelming situation based on the type of product that is being manufactured. Hence, some manufacturers of new drug products have made inadvertent mistakes in the design of their new drug stability testing program. Such mistakes may ultimately delay the new, existing or modified product IND or NDA application process due to the data that was presented to the FDA (i.e. Relevant aspects of the stability testing program requirement may have been omitted by the drug manufacturers). It is better to understand, follow and apply the full requirements of a new product stability testing requirement from the onset or to correct an existing stability testing program so as to avoid future pitfalls and delayed IND or NDA submission process by the FDA. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA's Drug Stability Testing Program, NDA submission, 21CFR 514.1(b)(5)(x) expectations, Analytical Testing Considerations
17.
 
Pharmaceutical Supply Chain Integrity - Good Distribution Practices (GDP)
ID
810970
Dates
04 jul 2016 - 05 jul 2016
Lieu
Shanghai, États-Unis
Résumé
In China's latest public health scandal over the alleged illegal distribution of improperly stored vaccines that has reignited drug-safety concerns in China. According to state media, vaccines valued at almost $90 million have been distributed across the country. The health regulator says the vaccines were all produced by licensed manufacturers, but were stored and transported without proper refrigeration.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Good Distribution Practice, GDP with GMP, supply chain, risk management, PIC/S, GDP (GWP) regulations, GSP, GWP
18.
 
FASEB SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
ID
786115
Dates
24 jul 2016 - 29 jul 2016
Lieu
Big Sky, Montana, États-Unis
Résumé
This FASEB Science Research Conference will bring a greater understanding of the biochemical and molecular mechanisms underlying diseases associated with dysfunction in the neuroimmune system will undoubtedly facilitate the translational aspect of this field as novel therapeutic targets are moved towards human clinical trials. This will be facilitated by cutting-edge talks from scientists with international reputations on the topics of 1) CNS Metabolism and the Microbiome; 2) Inflammation in the Peripheral Nervous System; 3) Stem Cells and Neuroinflammation; 4) Neuroinflammatory Mechanisms of Demyelinating Diseases; 5) Immunity and Neurodegenerative Diseases; 6) Pre-clinical Studies for CNS Neuroinflammatory Diseases; 7) Neuroinflammation and Neurotrauma; 8) Neuroinflammation and Host Defense; and 9) The Many Faces of Microglia. In addition, this SRC will host a pre-meeting workshop entitled
Contact
FASEB SRC Staff;     Tél.: [3016347010];     Email.: SRC@faseb.org
Sujets apparentés
19.
 
7th Annual Global Pharma Summit
ID
802980
Dates
22 aou 2016 - 24 aou 2016
Lieu
New Orleans, États-Unis
Résumé
Pharma-2016 is a global conclave to discuss and learn about the sessions viz., Pharmaceutical Preformulation, Novel Drug Delivery Systems, Pharma Nanotechnology, Clinical Pharmacy, Pharmacology and Toxicology, Pharmacognosy and Phytochemistry, Pharmacy Practice, Medicinal Chemistry, Industrial Pharmacy, Regulatory Authorities, Bio and Chemo informatics, Market analysis and Business Opportunity.
20.
 
Drug Discovery & Therapy World Congress 2016 (4th in the Series)
ID
797101
Dates
22 aou 2016 - 25 aou 2016
Lieu
Boston, MA, États-Unis
Résumé
This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.
Contact
Hasina Habib;     Tél.: [+1-857-2398855];     Email.: hasinahabib@eurekaconference.com
Sujets
Academic CRO/Industrial collaborations in drug discovery Anti-Infectives Bioactive Lipids Biologics Clinical Trials and Regulatory Affairs Cancer Targeted Drug Delivery Cardiovascular Drug Discovery & Therapy Chemistry Combinatorial Chemistry CNS Drug Discovery & Therapy Diabetes and Obesity Drug Discovery & Therapy Drug Delivery & Targeting Drug Discovery in Preclinical Research Drug Metabolism Enabling Technologies Genomics Green Techniques for Medicinal Chemistry High-throughput Screening & Laboratory automation Hot Topics in Drug Targets Hot Topics in HIV Research Hot Topics in Medicinal Chemistry Hot Topics in Natural Products Inflammation and Immunology Innovative Drug Discovery and Nanotechnology In-silico Drug Design and in-silico screening Medical Imaging Nutraceutical Drug Discovery & Therapy Pharmaceutical Biotechnology Pharmaceutical Research & Development Pharmacogenomics Process Chemistry and Drug Manufacturing Protein and Peptide Sciences Proteomics & Bioinformatics Pulmonary Drug Discovery & Therapy Recent Advances in Patient Treatment and Care Recent Advances in Spectroscopy Regenerative Medicine Stereoselective Synthesis of Bioactive Compounds Structural Biology Systems Biology in Drug Design Traditional Chinese Medicine Translational Medicine Women’s Health Drug Discovery & Therapy
21.
 
11th Drug Design & Medicinal Chemistry Conference
ID
806727
Dates
12 sep 2016 - 13 sep 2016
Lieu
Boston, États-Unis
Résumé
We invite you to attend the 11th Drug Design & Medicinal Chemistry Conference, which will take place September 12-13, 2016 in Boston, MA. This meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Drug Design, Medicinal Chemistry
22.
 
2016 Pharma CI USA Conference & Exhibition
ID
807071
Dates
13 sep 2016 - 14 sep 2016
Lieu
Parsippany, NJ, États-Unis
Résumé
The Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives! The 2016 Pharma CI USA Conference & Exhibition (Sept. 13-14, 2016, Parsippany, NJ) is the industry's gold standard for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.
Contact
Ross Frasier;     Email.: ross@pharmaciconference.com
Sujets
pharma, pharmaceutical, biopharma, competitive intelligence, business intelligence
23.
 
BPA — BioPharm America™ 2016—9th Annual International Partnering Conference
ID
795848
Dates
13 sep 2016 - 15 sep 2016
Lieu
Boston, États-Unis
Résumé
Beginning its ninth year as an industry event, BioPharm America™ creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
Sujets
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
24.
 
DOT — 14th Annual Discovery on Target
ID
806826
Dates
19 sep 2016 - 22 sep 2016
Lieu
Boston, MA, États-Unis
Résumé
Cambridge Healthtech Institute will host the 14th Annual Discovery on Target event this September 19-22, 2016 in Boston, MA. Spanning four days, the event showcases current and emerging “hot” targets for the pharmaceutical industry. Over 1,100+ attendees (from 26 countries) composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations participate annually. The 2016 event is comprised of 17 conference tracks, 1 training seminar, 5 symposia, 16 short courses, an exhibit hall of 50+ companies, 135+ posters, and dedicated networking sessions. Discovery on Target assembles an impressive group of 300+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
Contact
Tél.: [7819725400];     Email.: chi@healthtech.com
Sujets
drug discovery, drug development, pharma, diseases, genomics, cancer
Sujets apparentés
25.
 
EYE — 4th Annual Targeting Ocular Disorders
ID
806770
Dates
20 sep 2016 - 21 sep 2016
Lieu
Boston, MA, États-Unis
Résumé
With its complex structure and the breadth of ocular disorders, the eye presents unique challenges to drug discovery. Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference provides a platform to discuss novel targets and disease pathways, the latest drug delivery methods, and the most promising emerging therapies. A special focus will be on gene therapy, stem cell therapies, and treatments outside of the well-established anti-VEGF therapies. The event will cover a broad range of diseases including but not limited to glaucoma, wet and dry age‐related and diabetic macular degeneration, retinopathy and retinitis pigmentosa.
Contact
Tél.: [7819725400];     Email.: chi@healthtech.com
Sujets
ophthalmology, retinal diseases, gene therapy, ocular disorders, drug delivery, stem cells
Sujets apparentés
26.
 
World ADC — World ADC San Diego
ID
803074
Dates
10 oct 2016 - 13 oct 2016
Lieu
San Diego, États-Unis
Résumé
Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. 
Contact
Jenny Barlow;     Tél.: [+1 212 537 5898];     Email.: info@hansonwade.com
Sujets
Develop Next Generation Clinically Transformative ADCs 2016 is set to be a momentous year for antibody-drug conjugates. Since the start of 2016 alone 3 new ADCs have entered human testing, joining the 54 ADCs already in clinical trials. The ADC industry is on the cusp of realizing the next therapeutic breakthrough. Rapidly diversifying payload, linker and antibody technologies and a surge of novel preclinical ADCs powering towards the clinic have all contributed to this gaining of momentum. Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. Covering the A-Z of ADCs, World ADC San Diego strikes the balance between distilling ground-breaking science with transformative research that will empower your programs tomorrow. This year, 650 prominent minds from 190 organisations will descend on World ADC San Diego giving you an unparalleled opportunity to foster new connections, catch-up with peers and progress business partnerships.
27.
 
IMN — 8th Annual Immunogenicity and Bioassay Summit
ID
811185
Dates
26 oct 2016 - 28 oct 2016
Lieu
Baltimore, MD, États-Unis
Résumé
Following year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.
Contact
Tél.: [781-972-5400];     Email.: chi@healthtech.com
Sujets
Immunogenicity, Clinical Relevance, Bioassays, Biologics
28.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811294
Dates
20 fév 2017 - 22 fév 2017
Lieu
Baltimore, États-Unis
Résumé
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Tél.: [1-302-231-6959];     Email.: Vaccines@madrige.com
Sujets
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Sujets apparentés

États-Unis: liste de tous les évènements/conférences.

Bon à savoir...

Vous pouvez insérer un encadré afin de diffuser vos évènements et services dans cet espace.

Dernière mise à jour: 30 Octobre 2079